Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEngage Xr Regulatory News (EXR)

Share Price Information for Engage Xr (EXR)

Share Price is delayed by 15 minutes
Get Live Data
0.215    0.00 (0.00%)
Bid:
0.18
Ask:
0.25
Spread: 0.07 (38.889%)
Market Cap: £1.13m
EXR Live PriceLast checked at - London Stock Exchange

Intraday Engage Xr Share Chart

Director/PDMR Shareholding

27 Sep 2007 16:50

Expro International Group PLC27 September 2007 NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIALRESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.(2) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes in block capital letters. 1. Name of the issuer Expro International Group PLC.................................... 2. State whether the notification relates to (i) a transaction notified inaccordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (asextended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) (iii).................................... 3. Name of person discharging managerial responsibilities/director Michael Speakman, Director.................................... 4. State whether notification relates to a person connected with a persondischarging managerial responsibilities/director named in 3 and identify theconnected person No.................................... 5. Indicate whether the notification is in respect of a holding of the personreferred to in 3 or 4 above or in respect of a non-beneficial interest In respect of a holding of Michael Speakman.................................... 6. Description of shares (including class), debentures or derivatives orfinancial instruments relating to shares Ordinary shares of 10p.................................... 7. Name of registered shareholders(s) and, if more than one, the number ofshares held by each of them Michael Speakman - 59,512 Helen Speakman - 20,000.................................... 8 State the nature of the transaction Exercise of share award under the Expro International Group Performance SharePlan 2003 and immediate sale of part only of the shares arising .................................... 9. Number of shares, debentures or financial instruments relating to sharesacquired 86,340 ordinary shares of 10p.................................... 10. Percentage of issued class acquired (treasury shares of that class shouldnot be taken into account when calculating percentage) 0.07%.................................... 11. Number of shares, debentures or financial instruments relating to sharesdisposed 35,499 ordinary shares of 10p.................................... 12. Percentage of issued class disposed (treasury shares of that class shouldnot be taken into account when calculating percentage) 0.03%.................................... 13. Price per share or value of transaction Exercise of award - £1.00 in total Sale of shares - 1012.2922p.................................... 14. Date and place of transaction 27 September; London.................................... 15. Total holding following notification and total percentage holding followingnotification (any treasury shares should not be taken into account whencalculating percentage) 79,512 ordinary shares of 10p; 0.07%.................................... 16. Date issuer informed of transaction 27 September 2007.................................... If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes 17 Date of grant .................................... 18. Period during which or date on which it can be exercised .................................... 19. Total amount paid (if any) for grant of the option .................................... 20. Description of shares or debentures involved (class and number) .................................... .................................... 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at the time of exercise .................................... 22. Total number of shares or debentures over which options held followingnotification .................................... 23. Any additional information .................................... 24. Name of contact and telephone number for queries Melanie Cox 0118 952 8378.................................... Name and signature of duly authorised officer of issuer responsible for makingnotification Melanie Cox, Deputy Company Secretary.................................... Date of notification 27 September 2007.................................... END This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Mar 202312:00 pmRNSResult of EGM
27th Feb 20233:45 pmRNSSigning of Subscription Agreement and TVR
7th Feb 202311:45 amRNSPosting of Circular
6th Feb 202312:00 pmRNS£8.8 million Placing
6th Feb 20237:00 amRNSProposed Placing of New Ordinary Shares
31st Jan 202311:05 amRNSSecond Price Monitoring Extn
31st Jan 202311:00 amRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSENGAGE showcases first AI-powered virtual employee
18th Jan 20237:00 amRNSFY2022 Trading Update and Notice of Results
12th Dec 20222:05 pmRNSSecond Price Monitoring Extn
12th Dec 20222:00 pmRNSPrice Monitoring Extension
12th Dec 202211:05 amRNSSecond Price Monitoring Extn
12th Dec 202211:00 amRNSPrice Monitoring Extension
12th Dec 20227:00 amRNSTrading Update
21st Nov 20227:00 amRNSCommercial reseller agreement signed with Lenovo
7th Nov 20227:00 amRNSLaunch of ENGAGE Link & Investor Presentation
28th Sep 202211:00 amRNSENGAGE XR to collaborate with Lenovo
21st Sep 20222:09 pmRNSHolding(s) in Company
13th Sep 20227:00 amRNSInterim Results
16th Aug 20227:00 amRNSInvestor Presentation
2nd Aug 20227:00 amRNSPre-Close Trading Update and Notice of Results
18th Jul 202211:00 amRNSDirectors’ Disclosure
23rd Jun 20227:00 amRNSENGAGE & METAVERSE UPDATE
16th Jun 202211:58 amRNSResult of AGM
16th May 20224:11 pmRNSNotice of AGM, Posting of Annual Report & Accounts
7th Apr 20224:40 pmRNSSecond Price Monitoring Extn
7th Apr 20224:35 pmRNSPrice Monitoring Extension
7th Apr 20227:00 amRNSEngage and Victory XR to Launch 10 Metaversities
28th Mar 20227:00 amRNSNew Senior Appointments to help drive US Growth
8th Mar 20227:01 amRNSFinal Results
4th Mar 202211:30 amRNSAIM Rule 17 Schedule 2(g) Update
16th Feb 20227:00 amRNSNotice of Results & Investor Presentation
31st Jan 20227:00 amRNSPre-Close Trading Update & Directorate Change
23rd Nov 20217:00 amRNSDirectorate Changes
12th Nov 20217:00 amRNSENGAGE Update & Investor Presentation
5th Nov 202110:24 amRNSExercise of Options
1st Jul 20081:02 pmRNSDirector Dealings
1st Jul 200811:16 amRNSScheme Effective
30th Jun 20085:52 pmRNSHolding(s) in Company
30th Jun 20083:03 pmRNSRule 8.3- Expro International
30th Jun 20082:19 pmBUSRule 8.3 - Expro International
30th Jun 200812:52 pmRNSEPT Disclosure - Expro Intern
30th Jun 200812:42 pmRNSEPT Disclosure - Expro Intl G
30th Jun 200812:37 pmRNSEPT Disclosure - Expro Intern
30th Jun 200812:11 pmRNSRule 8.3- Expro International
30th Jun 200811:16 amRNSHolding(s) in Company
30th Jun 200811:03 amRNSScheme of arrangement
27th Jun 20085:01 pmRNSRule 2.10 Announcement
27th Jun 20085:00 pmRNSSuspension - Expro Internatio
27th Jun 20084:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.